BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 10820252)

  • 1. Differential effect of cytokine treatment on Fc alpha receptor I- and Fc gamma receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages.
    Keler T; Wallace PK; Vitale LA; Russoniello C; Sundarapandiyan K; Graziano RF; Deo YM
    J Immunol; 2000 Jun; 164(11):5746-52. PubMed ID: 10820252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bispecific molecules directed to the Fc receptor for IgA (Fc alpha RI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood.
    Deo YM; Sundarapandiyan K; Keler T; Wallace PK; Graziano RF
    J Immunol; 1998 Feb; 160(4):1677-86. PubMed ID: 9469424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
    Watanabe M; Wallace PK; Keler T; Deo YM; Akewanlop C; Hayes DF
    Breast Cancer Res Treat; 1999 Feb; 53(3):199-207. PubMed ID: 10369066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human Fc receptor for IgA (Fc alpha RI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysis.
    van Egmond M; Hanneke van Vuuren AJ; van de Winkel JG
    Immunol Lett; 1999 May; 68(1):83-7. PubMed ID: 10397160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant IFN-gamma (rIFN-gamma) on the mechanism of human macrophage IgG FcRI-mediated cytotoxicity. rIFN-gamma decreases inhibition by cytophilic human IgG and changes the cytolytic mechanism.
    Van Schie RC; Verstraten RG; Van de Winkel JG; Tax WJ; de Mulder PH
    J Immunol; 1992 Jan; 148(1):169-76. PubMed ID: 1530794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the antibody-dependent cytotoxic capabilities of individual human monocytes. Role of Fc gamma RI and Fc gamma RII and the effects of cytokines at the single cell level.
    Connor RI; Shen L; Fanger MW
    J Immunol; 1990 Sep; 145(5):1483-9. PubMed ID: 1696598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells.
    Erbe DV; Collins JE; Shen L; Graziano RF; Fanger MW
    Mol Immunol; 1990 Jan; 27(1):57-67. PubMed ID: 2138246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bispecific antibody-dependent cellular cytotoxicity of HER2/neu-overexpressing tumor cells by Fc gamma receptor type I-expressing effector cells.
    Keler T; Graziano RF; Mandal A; Wallace PK; Fisher J; Guyre PM; Fanger MW; Deo YM
    Cancer Res; 1997 Sep; 57(18):4008-14. PubMed ID: 9307286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.
    Guettinger Y; Barbin K; Peipp M; Bruenke J; Dechant M; Horner H; Thierschmidt D; Valerius T; Repp R; Fey GH; Stockmeyer B
    J Immunol; 2010 Feb; 184(3):1210-7. PubMed ID: 20042573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of low-affinity Fc receptors in antibody-dependent tumor cell phagocytosis by human monocyte-derived macrophages.
    Munn DH; McBride M; Cheung NK
    Cancer Res; 1991 Feb; 51(4):1117-23. PubMed ID: 1825476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-interferon inhibits Fc receptor II-mediated phagocytosis of tumor cells by human macrophages.
    Backman KA; Guyre PM
    Cancer Res; 1994 May; 54(9):2456-61. PubMed ID: 7909275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules, including the Fc gamma R.
    Connor RI; Dinces NB; Howell AL; Romet-Lemonne JL; Pasquali JL; Fanger MW
    Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9593-7. PubMed ID: 1835086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-mediated erythrolysis and erythrophagocytosis by human monocytes, macrophages and activated macrophages. Evidence for distinction between involvement of high-affinity and low-affinity receptors for IgG by using different erythroid target cells.
    Rüegg SJ; Jungi TW
    Immunology; 1988 Mar; 63(3):513-20. PubMed ID: 2965100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF-stimulated PMN in immunotherapy of breast cancer with a bispecific antibody to Fc gamma RI and to HER-2/neu (MDX-210).
    Repp R; Valerius T; Wieland G; Becker W; Steininger H; Deo Y; Helm G; Gramatzki M; Van de Winkel JG; Lang N
    J Hematother; 1995 Oct; 4(5):415-21. PubMed ID: 8581378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering Fc alpha-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy.
    Stockmeyer B; Dechant M; van Egmond M; Tutt AL; Sundarapandiyan K; Graziano RF; Repp R; Kalden JR; Gramatzki M; Glennie MJ; van de Winkel JG; Valerius T
    J Immunol; 2000 Nov; 165(10):5954-61. PubMed ID: 11067958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
    Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
    Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies combining bispecific antibodies with cytokine-stimulated effector cells for immunotherapy of renal cell carcinoma.
    Elsässer D; Stadick H; Stark S; Van de Winkel JG; Gramatzki M; Schrott KM; Valerius T; Schafhauser W
    Anticancer Res; 1999; 19(2C):1525-8. PubMed ID: 10365137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of IgA, IgE, and IgG Fc receptor expression on human mononuclear phagocytes by 1 alpha,25-dihydroxyvitamin D3 and cytokines.
    Boltz-Nitulescu G; Willheim M; Spittler A; Leutmezer F; Tempfer C; Winkler S
    J Leukoc Biol; 1995 Aug; 58(2):256-62. PubMed ID: 7643018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical studies with Fc(gamma)R bispecific antibodies and granulocyte colony-stimulating factor-primed neutrophils as effector cells against HER-2/neu overexpressing breast cancer.
    Stockmeyer B; Valerius T; Repp R; Heijnen IA; Bühring HJ; Deo YM; Kalden JR; Gramatzki M; van de Winkel JG
    Cancer Res; 1997 Feb; 57(4):696-701. PubMed ID: 9044847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors.
    Otten MA; Rudolph E; Dechant M; Tuk CW; Reijmers RM; Beelen RH; van de Winkel JG; van Egmond M
    J Immunol; 2005 May; 174(9):5472-80. PubMed ID: 15843545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.